FDA Grants Priority Review Voucher to Chimerix Inc. for Pediatric Cancer Drug
August 28, 2025
August 28, 2025
WASHINGTON, Aug. 28 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has awarded a priority review voucher to Chimerix Inc., Durham, North Carolina, for its medication, Modesyo.
This action by the FDA is part of a program to encourage the development of treatments for rare pediatric diseases. The voucher, which can be used to speed up the review of a future product or be sold to another company, serves as an incentive for drug manufacturers to . . .
This action by the FDA is part of a program to encourage the development of treatments for rare pediatric diseases. The voucher, which can be used to speed up the review of a future product or be sold to another company, serves as an incentive for drug manufacturers to . . .